Christoph Herbel

Title: Christoph Herbel - Innovator in Personalized Cell Therapy

Introduction

Christoph Herbel is an inventor based in Overath, Germany. He is associated with Miltenyi Biotec B.V. & Co. KG, a company known for its advancements in biotechnology. Although he currently holds no granted patents, his work focuses on innovative methods in the field of personalized medicine.

Latest Patent Applications

One of Christoph Herbel's notable patent applications is titled "Method for providing personalized cells with chimeric antigen receptors (CAR)." This invention is directed towards a method for providing a cell that comprises a chimeric antigen receptor (CAR) specific for one or more target antigens exposed on tumor cells. The method involves providing a cell sample that includes both tumor and non-tumor cells. It includes steps such as contacting the cell tissue with a conjugate that has a fluorescent moiety and an antigen recognizing moiety, removing unbound conjugate, and detecting cells bound to the conjugate through fluorescence radiation. The process continues by erasing the fluorescence emitted by the conjugates and using different conjugates to identify at least two antigen recognizing moieties. This allows for the discrimination between tumor cells and non-tumor cells, ultimately providing cells with the identified antigen recognizing moieties as chimeric antigen receptors (CAR).

Conclusion

Christoph Herbel is making significant contributions to the field of personalized cell therapy through his innovative methods. His work has the potential to advance cancer treatment by improving the specificity of therapeutic cells.